Camden National Corporation’s Xylem XYL Stock Holding History

Camden National Corporation’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$9.93M	Buy	+94,384	New	+$9.57M	1.98%	15

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Camden National Corporation's XYL Position: Q1 2021 in Review

Camden National Corporation opened a new position in Xylem (XYL) in Q1 2021: 94,384 shares worth $9.93M. The stake represents 1.98% of the portfolio and ranks #15 among its holdings.

748 funds tracked by Wall St. Rank hold XYL as of Q1 2021.

Camden National Corporation held 94,384 shares of Xylem worth $9.93M as of Q1 2021.
Xylem was a new Camden National Corporation position in Q1 2021.
Xylem made up 1.98% of Camden National Corporation's portfolio in Q1 2021, its #15 holding.
748 funds tracked by Wall St. Rank held Xylem as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.